Literature DB >> 21550168

MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.

Syunsuke Noguchi1, Takashi Mori, Yuki Hoshino, Kohji Maruo, Nami Yamada, Yukio Kitade, Tomoki Naoe, Yukihiro Akao.   

Abstract

MicroRNA (miR)-143 and -145 were down-regulated in human bladder cancer T24 cells. The enforced expression of miR-143 induced growth-suppression in T24 cells through down-regulation of ERK5 and Akt expression at translational level, and chemically-modified synthetic miR-143 (miR-143/BP) exhibited a greater growth inhibitory effect than wild-type miR-143. In addition, the synthetic miR-143/BP induced apoptotic cell death in some of the transfected cells. Furthermore, co-treatment with the synthetic miR-143/BP and cisplatin showed the additive growth-suppressing effect on T24 cells. These findings suggest that the chemically-modified synthetic miR-143 functions as a tumor suppressor in T24 cells by targeting ERK5 and/or Akt.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21550168     DOI: 10.1016/j.canlet.2011.04.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  63 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

Review 2.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.

Authors:  Akira Kurozumi; Yusuke Goto; Atsushi Okato; Tomohiko Ichikawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

3.  Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.

Authors:  Ntube N O Ngalame; Ngome L Makia; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-22       Impact factor: 4.219

4.  MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b.

Authors:  Shunsuke Noguchi; Minami Kumazaki; Yuki Yasui; Takashi Mori; Nami Yamada; Yukihiro Akao
Journal:  J Invest Dermatol       Date:  2013-07-22       Impact factor: 8.551

5.  Chemically modified synthetic microRNA-205 inhibits the growth of melanoma cells in vitro and in vivo.

Authors:  Shunsuke Noguchi; Junya Iwasaki; Minami Kumazaki; Takashi Mori; Kohji Maruo; Hiroki Sakai; Nami Yamada; Kazuyuki Shimada; Tomoki Naoe; Yukio Kitade; Yukihiro Akao
Journal:  Mol Ther       Date:  2013-04-30       Impact factor: 11.454

6.  Deregulation of miR-93 and miR-143 in human esophageal cancer.

Authors:  Mohammad Hossein Ansari; Shiva Irani; Houri Edalat; Ruhul Amin; Amaneh Mohammadi Roushandeh
Journal:  Tumour Biol       Date:  2015-10-01

7.  Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.

Authors:  Emmanuel I Papadopoulos; Andreas Scorilas
Journal:  Clin Transl Sci       Date:  2015-09-10       Impact factor: 4.689

8.  MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6.

Authors:  Feng Xue; Jiwei Yin; Lin Xu; Boqing Wang
Journal:  Exp Ther Med       Date:  2017-04-18       Impact factor: 2.447

9.  Iodine-125 irradiation inhibits invasion of gastric cancer cells by reactivating microRNA-181c expression.

Authors:  Yong Yang; Zhen-Huan Ma; Xiao-Gang Li; Wan-Fu Zhang; Jia Wan; Ling-Juan Du; Guo-Jian Li; Guo-Kai Yang; Ping Lu
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

Review 10.  Aberrant expression of microRNAs in bladder cancer.

Authors:  Hirofumi Yoshino; Naohiko Seki; Toshihiko Itesako; Takeshi Chiyomaru; Masayuki Nakagawa; Hideki Enokida
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.